Method of treating Parkinson's disease with intranasal delivery of insulin and glutathione
US11813313B2 · kind B2 · utility
0Cited by
5References
10Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jan 26, 2022 |
| Grant date | Nov 14, 2023 |
| Priority date | — |
| Expiry date | Jan 26, 2042 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/16
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for treating Parkinson's disease where insulin and GSH may be administered intranasally. The GSH and insulin that is administered may be in varying doses at least once daily. The GSH and insulin may be administered sequentially and/or simultaneously and the medications may be administered for differing periods of time depending upon a patient's tolerance and response to the GSH and insulin. The GSH and the insulin may be administered for a certain period of time and/or indefinitely.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.